Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Cerchione

Showing results (61-70 of 127) with videos related to

Pageof 13
Sort By:
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 1, 2017
Secondary syphilis mimicking malignancy: A case report and review of literatureClaudio Cerchione, Alberto Enrico Maraolo, Luana Marano, et al.
Expert Review of Hematology|August 23, 2021
Safety of FLT3 inhibitors in patients with acute myeloid leukemiaClaudio Cerchione, Andrés Peleteiro Raíndo, Adrián Mosquera Orgueira, et al.
Cancers|February 24, 2024
Baseline IgM Amounts Can Identify Patients with Poor Outcomes: Results from a Real-Life Single-Center Study on Classical Hodgkin LymphomaAndrea Duminuco, Gabriella Santuccio, Annalisa Chiarenza, et al.
Panminerva Medica|September 21, 2020
CAR T cells targeting options in the fight against multiple myelomaFabio Nicolini, Sara Bravaccini, Massimiliano Mazza, et al.
Frontiers in Oncology|February 25, 2022
Gene Expression Profiling in Multiple Myeloma: Redefining the Paradigm of Risk-Adapted TreatmentClaudio Cerchione, Saad Z Usmani, A Keith Stewart, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 2, 2019
A Frontline Approach With Peripherally Inserted Versus Centrally Inserted Central Venous Catheters for Remission Induction Chemotherapy Phase of Acute Myeloid Leukemia: A Randomized ComparisonMarco Picardi, Roberta Della Pepa, Claudio Cerchione, et al.
Translational Oncology|September 19, 2022
Why the complications of COVID-19 patients differ in elderly and young cancer patientsSara Bravaccini, Fabio Nicolini, Michele Zanoni, et al.
Journal for Immunotherapy of Cancer|October 18, 2019
CAR-T cell therapy: a potential new strategy against prostate cancerGiuseppe Schepisi, Maria Concetta Cursano, Chiara Casadei, et al.
Frontiers in Oncology|April 26, 2021
IDH1/IDH2 Inhibition in Acute Myeloid LeukemiaClaudio Cerchione, Alessandra Romano, Naval Daver, et al.
Cancers|September 28, 2021
Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab OzogamicinMichele Gottardi, Giorgia Simonetti, Alessandra Sperotto, et al.
Pageof 13

Showing results (61-70 of 127) with videos related to

Sort By:
Pageof 13
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 1, 2017
Secondary syphilis mimicking malignancy: A case report and review of literatureClaudio Cerchione, Alberto Enrico Maraolo, Luana Marano, et al.
Expert Review of Hematology|August 23, 2021
Safety of FLT3 inhibitors in patients with acute myeloid leukemiaClaudio Cerchione, Andrés Peleteiro Raíndo, Adrián Mosquera Orgueira, et al.
Cancers|February 24, 2024
Baseline IgM Amounts Can Identify Patients with Poor Outcomes: Results from a Real-Life Single-Center Study on Classical Hodgkin LymphomaAndrea Duminuco, Gabriella Santuccio, Annalisa Chiarenza, et al.
Panminerva Medica|September 21, 2020
CAR T cells targeting options in the fight against multiple myelomaFabio Nicolini, Sara Bravaccini, Massimiliano Mazza, et al.
Frontiers in Oncology|February 25, 2022
Gene Expression Profiling in Multiple Myeloma: Redefining the Paradigm of Risk-Adapted TreatmentClaudio Cerchione, Saad Z Usmani, A Keith Stewart, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 2, 2019
A Frontline Approach With Peripherally Inserted Versus Centrally Inserted Central Venous Catheters for Remission Induction Chemotherapy Phase of Acute Myeloid Leukemia: A Randomized ComparisonMarco Picardi, Roberta Della Pepa, Claudio Cerchione, et al.
Translational Oncology|September 19, 2022
Why the complications of COVID-19 patients differ in elderly and young cancer patientsSara Bravaccini, Fabio Nicolini, Michele Zanoni, et al.
Journal for Immunotherapy of Cancer|October 18, 2019
CAR-T cell therapy: a potential new strategy against prostate cancerGiuseppe Schepisi, Maria Concetta Cursano, Chiara Casadei, et al.
Frontiers in Oncology|April 26, 2021
IDH1/IDH2 Inhibition in Acute Myeloid LeukemiaClaudio Cerchione, Alessandra Romano, Naval Daver, et al.
Cancers|September 28, 2021
Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab OzogamicinMichele Gottardi, Giorgia Simonetti, Alessandra Sperotto, et al.
Pageof 13